About Event

As the drive for smarter, faster, and more efficient drug discovery intensified, leveraging structural insights across proteins, complexes, and multi‑modal targets became more critical than ever. Advances in Cryo‑EM, X-ray crystallography, NMR, HDX‑MS, and AI‑driven modelling enabled researchers to visualize dynamic targets, uncover hidden pockets, and guide the rational design of small molecules, biologics, and complex modalities.

Built by biopharma for biopharma, the Structure-Based Drug Design Summit made its West Coast debut in San Diego this February, bringing together structural biologists, medicinal chemists, computational chemists, and protein engineers. Attendees shared best practices, explored real‑world applications, and learned how to integrate structural and computational insights to optimize candidates, reduce attrition, and accelerate discovery.